High-affinity sequence-selective DNA binding by iridium(III) polypyridyl organometallopeptides

Area of Science:

• Organometallic Chemistry
• Medicinal Chemistry
• Bioconjugation

Background:

• Organometallopeptides offer unique properties for biomedical applications.
• Iridium(III) complexes are explored for their photophysical and cytotoxic potential.
• Peptide synthesis is crucial for creating targeted drug delivery systems.

Purpose of the Study:

• To synthesize polynuclear Iridium(III) organometallopeptides.
• To evaluate the DNA binding affinity and sequence selectivity of these compounds.
• To assess the cytotoxicity of oligoarginine-containing Iridium(III) derivatives against cancer cell lines.

Main Methods:

• Solid-phase peptide synthesis for organometallopeptide assembly.
• Spectroscopic characterization of synthesized compounds.
• In vitro cytotoxicity assays on various cancer cell lines.

Main Results:

• Successful straightforward assembly of polynuclear Iridium(III) organometallopeptides.
• Oligoarginine derivatives demonstrated high DNA binding affinity.
• Significant sequence selectivity in DNA binding was observed.
• High cytotoxicity was exhibited towards tested cancer cell lines.

Conclusions:

• Solid-phase synthesis is an effective method for creating Iridium(III) organometallopeptides.
• Oligoarginine-functionalized Iridium(III) complexes show promise as anticancer agents.
• These compounds possess desirable DNA-binding properties for potential therapeutic applications.